Related Experiment Video
Updated: Oct 6, 2025

High Content Screening in Neurodegenerative Diseases
Published on: January 6, 2012
Recent advances in preventing neurodegenerative diseases
Shih-Ching Chou1,2, Akanksha Aggarwal1,3, Valina L Dawson1,4,5,6
1Neuroregeneration and Stem Cell Programs, Institute for Cell Engineering, 733 North Broadway, Johns Hopkins University School of Medicine, Baltimore, MD 21205, USA.
Neurodegenerative diseases pose a growing global health challenge due to limited treatments. This review summarizes novel neuroprotective strategies targeting neuronal cell death, protein aggregation, and neuroinflammation for conditions like Alzheimer's and Parkinson's disease.
Area of Science:
- Neuroscience
- Pharmacology
- Biomedical Research
Background:
- Rising global health burden of neurodegenerative diseases (NDDs).
- Limitations of current pharmacotherapy for NDDs.
- Increasing incidence of NDDs like Alzheimer's, Parkinson's, and ALS.
Purpose of the Study:
- To review and summarize recent advancements in neuroprotective strategies for NDDs.
- To highlight novel therapeutic targets for neurodegenerative disorders.
- To address the urgent need for effective NDD treatments.
Main Methods:
- Literature review of recent research and clinical trials.
- Analysis of studies focusing on shared pathophysiologic mechanisms in NDDs.
- Synthesis of findings on novel neuroprotective compounds and interventions.
Main Results:
- Identification of key research targets: neuronal cell death, mitochondrial dysfunction, protein aggregation, and neuroinflammation.
- Growing understanding of NDD pathophysiologic mechanisms.
- Discovery of numerous novel neuroprotective therapeutic targets.
Conclusions:
- Advancements in understanding NDDs have revealed promising neuroprotective targets.
- Novel strategies are emerging to combat neurodegeneration.
- Further research is crucial for developing effective treatments for NDDs.
Related Concept Videos
Alzheimer's Disease: Overview
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
Alzheimer's Disease: Treatment
Parkinson's Disease: Overview
Parkinson's Disease: Treatment
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Cognitive Enhancers: Cholinesterase Inhibitors and NMDA Receptor Antagonists
Neurogenesis and Regeneration of Nervous Tissue

